AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
20 Diciembre 2023 - 3:05PM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present at the 42nd Annual J.P. Morgan Healthcare
Conference on Wednesday, January 10, 2024, at 2:15 p.m. Pacific
Time (5:15 p.m. Eastern Time).
A live audio webcast of the presentation may be accessed through
a link that will be posted on AbCellera's Investor Relations
website. A replay will be available through the same link following
the presentation.
About AbCellera Biologics Inc. AbCellera is breaking the
barriers of conventional antibody discovery to bring better
medicines to patients, sooner. AbCellera’s engine integrates expert
teams, technology, and facilities with the data science and
automation needed to propel antibody-based medicines from target to
clinic in nearly every therapeutic area with precision and speed.
AbCellera provides innovative biotechs and leading pharmaceutical
companies with a competitive advantage that empowers them to move
quickly, reduce cost, and tackle the toughest problems in drug
development. For more information, please visit
www.abcellera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231219949988/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Murray
McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor
Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
AbCellera Biologics (NASDAQ:ABCL)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
